Search
Soleno Therapeutics Inc
SLNOAdd to Watchlist
53.010USD
0.0000.00%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
2.76BMarket Cap
27.14P/E TTM
Financial Health
Currency: USD Updated: 2026-05-15 The current financial score of Soleno Therapeutics Inc is 9.17, ranking 11 out of 382 in the Biotechnology & Medical Research industry. Its financial status is robust, and its operating efficiency is high.
Financials
9.13
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
8.63
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
10.00
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
10.00
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
8.08
Free cash flow
Relevant data have not been disclosed by the company yet.